Lucid Genomics
Berlin, DE · 1 known investors
Lucid Genomics offers a long-read native genomics platform that handles variant calling, AI-driven prioritization, interpretation, and reporting for data from PacBio HiFi and Oxford Nanopore sequencing. It serves clinical and research genomics teams working on rare-disease diagnosis and discovery, including CLIA labs and diagnostic groups.
Investors · 1
Frequently asked questions
- What does Lucid Genomics do?
- Lucid Genomics offers a long-read native genomics platform that handles variant calling, AI-driven prioritization, interpretation, and reporting for data from PacBio HiFi and Oxford Nanopore sequencing. It serves clinical and research genomics teams working on rare-disease diagnosis and discovery, including CLIA labs and diagnostic groups.
- Who are Lucid Genomics's investors?
- Lucid Genomics's investors include Caesar Ventures.
- Where is Lucid Genomics headquartered?
- Lucid Genomics is headquartered in Berlin, DE.